These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 35140725)

  • 1. Epigenetic Modifications in Tumor-Associated Macrophages: A New Perspective for an Old Foe.
    Niu Y; Chen J; Qiao Y
    Front Immunol; 2022; 13():836223. PubMed ID: 35140725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation in the tumor microenvironment.
    Zhang MW; Fujiwara K; Che X; Zheng S; Zheng L
    J Zhejiang Univ Sci B; 2017 May; 18(5):365-372. PubMed ID: 28471108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets.
    Yang J; Xu J; Wang W; Zhang B; Yu X; Shi S
    Signal Transduct Target Ther; 2023 May; 8(1):210. PubMed ID: 37217462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of epigenetic modifications in the head and neck tumour microenvironment.
    Liu H; Wang D; Yang Z; Li S; Wu H; Xiang J; Kan S; Hao M; Liu W
    Front Immunol; 2022; 13():1050982. PubMed ID: 36405713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs: As Critical Regulators of Tumor- Associated Macrophages.
    Chatterjee B; Saha P; Bose S; Shukla D; Chatterjee N; Kumar S; Tripathi PP; Srivastava AK
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression.
    Saleh R; Toor SM; Sasidharan Nair V; Elkord E
    Front Immunol; 2020; 11():1469. PubMed ID: 32760400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics in cancer: targeting chromatin modifications.
    Ellis L; Atadja PW; Johnstone RW
    Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages.
    Chen D; Zhang X; Li Z; Zhu B
    Theranostics; 2021; 11(3):1016-1030. PubMed ID: 33391518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs); where do they stand in tumorigenesis and how they can change the face of cancer therapy?
    Tajaldini M; Saeedi M; Amiriani T; Amiriani AH; Sedighi S; Mohammad Zadeh F; Dehghan M; Jahanshahi M; Zanjan Ghandian M; Khalili P; Poorkhani AH; Alizadeh AM; Khori V
    Eur J Pharmacol; 2022 Aug; 928():175087. PubMed ID: 35679891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding the spatiotemporal heterogeneity of tumor-associated macrophages.
    Chu X; Tian Y; Lv C
    Mol Cancer; 2024 Jul; 23(1):150. PubMed ID: 39068459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Epigenetic-Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment.
    Zhang J; Huang L; Ge G; Hu K
    Adv Sci (Weinh); 2023 Mar; 10(7):e2206169. PubMed ID: 36599655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor associated macrophage and microbe: The potential targets of tumor vaccine delivery.
    Jiang J; Mei J; Yi S; Feng C; Ma Y; Liu Y; Liu Y; Chen C
    Adv Drug Deliv Rev; 2022 Jan; 180():114046. PubMed ID: 34767863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic inhibitors and their role in cancer therapy.
    Abdelaziz N; Therachiyil L; Sadida HQ; Ali AM; Khan OS; Singh M; Khan AQ; Akil ASA; Bhat AA; Uddin S
    Int Rev Cell Mol Biol; 2023; 380():211-251. PubMed ID: 37657859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolving landscape of N
    Gu Y; Wu X; Zhang J; Fang Y; Pan Y; Shu Y; Ma P
    Mol Ther; 2021 May; 29(5):1703-1715. PubMed ID: 33839323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation landscape of tumor-associated macrophages reveals pathways, transcription factors and prognostic value relevant to triple-negative breast cancer patients.
    Hey J; Halperin C; Hartmann M; Mayer S; Schönung M; Lipka DB; Scherz-Shouval R; Plass C
    Int J Cancer; 2023 Mar; 152(6):1226-1242. PubMed ID: 36408934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status.
    Dallavalasa S; Beeraka NM; Basavaraju CG; Tulimilli SV; Sadhu SP; Rajesh K; Aliev G; Madhunapantula SV
    Curr Med Chem; 2021; 28(39):8203-8236. PubMed ID: 34303328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers.
    Yen CY; Huang HW; Shu CW; Hou MF; Yuan SS; Wang HR; Chang YT; Farooqi AA; Tang JY; Chang HW
    Cancer Lett; 2016 Apr; 373(2):185-92. PubMed ID: 26808576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic control of the tumor microenvironment.
    Marks DL; Olson RL; Fernandez-Zapico ME
    Epigenomics; 2016 Dec; 8(12):1671-1687. PubMed ID: 27700179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of epigenetic reprogramming on antitumor immune responses in glioma.
    McClellan BL; Haase S; Nunez FJ; Alghamri MS; Dabaja AA; Lowenstein PR; Castro MG
    J Clin Invest; 2023 Jan; 133(2):. PubMed ID: 36647827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes: A Potential Therapeutic Tool Targeting Communications between Tumor Cells and Macrophages.
    Guo W; Li Y; Pang W; Shen H
    Mol Ther; 2020 Sep; 28(9):1953-1964. PubMed ID: 32563274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.